Literature DB >> 16612327

ABC transporter expression profiling after ischemic reperfusion injury in mouse kidney.

M Huls1, J J M W van den Heuvel, H B P M Dijkman, F G M Russel, R Masereeuw.   

Abstract

Renal ATP binding cassette (ABC) transporters have an important role in the elimination of metabolic waste products and compounds foreign to the body. The kidney has the ability to tightly control the expression of these efflux transporters to maintain homeostasis, and as a major mechanism of adaptation to environmental stress. In the present study, we investigated the expression of 45 ABC transporter genes in the mouse kidney under basal conditions, after induction of ischemia and after regeneration. Two days after clamping, mice showed a 76% decrease in renal creatinine clearance, which improved clearly within 7 days. This was confirmed by histological examinations. Seven days after ischemia, real-time quantitative Polymerase chain reaction data showed that transcript abundance of abcb1, abcb11, and abcc4 was increased, and that of abca3, abcc2, and abcg2 decreased. Expression of all transporters returned to baseline after 14 days, except for abcb11, which was reduced. Abcb11 is the major liver canalicular bile salt export pump. Here we show for the first time expression in the kidney and localization of the transporter to the apical membrane of proximal tubules. The presence of another novel renal transporter, abca3, was confirmed by Western blotting. Immunohistochemistry showed that abca3 is localized to the peritubular capillaries and apical membrane of proximal tubules. In conclusion, after inducing ischemic reperfusion injury in the kidney, ABC transporters appear to be differentially regulated, which might be associated with the renal regeneration process. Furthermore, we showed for the first time expression and subcellular localization of abcb11 and abca3 in mouse kidney.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16612327     DOI: 10.1038/sj.ki.5000407

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

1.  Description of two new ABCB11 mutations responsible for type 2 benign recurrent intrahepatic cholestasis in a French-Canadian family.

Authors:  Yannick Beauséjour; Fernando Alvarez; Martin Beaulieu; Marc Bilodeau
Journal:  Can J Gastroenterol       Date:  2011-06       Impact factor: 3.522

Review 2.  Regulatory pathways for ATP-binding cassette transport proteins in kidney proximal tubules.

Authors:  Rosalinde Masereeuw; Frans G M Russel
Journal:  AAPS J       Date:  2012-09-08       Impact factor: 4.009

3.  Retina Compatible Interactions and Effective Modulation of Blood Ocular Barrier P-gp Activity by Third-Generation Inhibitors Improve the Ocular Penetration of Loperamide.

Authors:  Karthik Yadav Janga; Akshaya Tatke; Surabhi Shukla; Surya P Lamichhane; Bharathi Avula; XiangDi Wang; Monica M Jablonski; Ikhlas A Khan; Soumyajit Majumdar
Journal:  J Pharm Sci       Date:  2018-04-17       Impact factor: 3.534

4.  Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes.

Authors:  Dong-Hyun Kim; Hoon-In Choi; Jung Sun Park; Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Redox Biol       Date:  2022-06-23       Impact factor: 10.787

5.  Regulation of P-glycoprotein in renal proximal tubule epithelial cells by LPS and TNF-alpha.

Authors:  Suzanne Heemskerk; Janny G P Peters; Jochem Louisse; Seil Sagar; Frans G M Russel; Rosalinde Masereeuw
Journal:  J Biomed Biotechnol       Date:  2010-03-09

6.  Purinergic signaling in the lumen of a normal nephron and in remodeled PKD encapsulated cysts.

Authors:  Michael B Hovater; Dragos Olteanu; Elisabeth A Welty; Erik M Schwiebert
Journal:  Purinergic Signal       Date:  2008-04-26       Impact factor: 3.765

Review 7.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

8.  Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.

Authors:  Henricus A M Mutsaers; Lambertus P van den Heuvel; Lauke H J Ringens; Anita C A Dankers; Frans G M Russel; Jack F M Wetzels; Joost G Hoenderop; Rosalinde Masereeuw
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

9.  Diannexin protects against renal ischemia reperfusion injury and targets phosphatidylserines in ischemic tissue.

Authors:  Kimberley E Wever; Frank A D T G Wagener; Cathelijne Frielink; Otto C Boerman; Gert J Scheffer; Anthony Allison; Rosalinde Masereeuw; Gerard A Rongen
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

Review 10.  Crosstalk Between Lipids and Mitochondria in Diabetic Kidney Disease.

Authors:  G Michelle Ducasa; Alla Mitrofanova; Alessia Fornoni
Journal:  Curr Diab Rep       Date:  2019-11-21       Impact factor: 5.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.